国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Pelobacter propionicus Tryptophan synthase alpha chain (trpA) CSB-YP372738PYF
CSB-EP372738PYF
CSB-BP372738PYF
CSB-MP372738PYF
CSB-EP372738PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Trigger factor (tig) CSB-YP372739PYF
CSB-EP372739PYF
CSB-BP372739PYF
CSB-MP372739PYF
CSB-EP372739PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus 7-cyano-7-deazaguanine synthase (queC) CSB-YP372740PYF
CSB-EP372740PYF
CSB-BP372740PYF
CSB-MP372740PYF
CSB-EP372740PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Putative cobalt-precorrin-6A synthase [deacetylating] (cbiD) CSB-YP372741PYF
CSB-EP372741PYF
CSB-BP372741PYF
CSB-MP372741PYF
CSB-EP372741PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (ispH) CSB-YP372742PYF
CSB-EP372742PYF
CSB-BP372742PYF
CSB-MP372742PYF
CSB-EP372742PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Phosphoribosylglycinamide formyltransferase 2 (purT) CSB-YP372743PYF
CSB-EP372743PYF
CSB-BP372743PYF
CSB-MP372743PYF
CSB-EP372743PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus ATP synthase subunit a 3 (atpB3), partial CSB-YP372744PYF1
CSB-EP372744PYF1
CSB-BP372744PYF1
CSB-MP372744PYF1
CSB-EP372744PYF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB) CSB-YP372745PYF
CSB-EP372745PYF
CSB-BP372745PYF
CSB-MP372745PYF
CSB-EP372745PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB CSB-YP372746PYF
CSB-EP372746PYF
CSB-BP372746PYF
CSB-MP372746PYF
CSB-EP372746PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus 50S ribosomal protein L32 (rpmF) CSB-YP372747PYF
CSB-EP372747PYF
CSB-BP372747PYF
CSB-MP372747PYF
CSB-EP372747PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Translation initiation factor IF-1 (infA) CSB-YP372748PYF
CSB-EP372748PYF
CSB-BP372748PYF
CSB-MP372748PYF
CSB-EP372748PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP372749PYF
CSB-EP372749PYF
CSB-BP372749PYF
CSB-MP372749PYF
CSB-EP372749PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus 30S ribosomal protein S2 (rpsB) CSB-YP372750PYF
CSB-EP372750PYF
CSB-BP372750PYF
CSB-MP372750PYF
CSB-EP372750PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP372751PYF
CSB-EP372751PYF
CSB-BP372751PYF
CSB-MP372751PYF
CSB-EP372751PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP372752PYF
CSB-EP372752PYF
CSB-BP372752PYF
CSB-MP372752PYF
CSB-EP372752PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus 50S ribosomal protein L35 (rpmI) CSB-YP372753PYF
CSB-EP372753PYF
CSB-BP372753PYF
CSB-MP372753PYF
CSB-EP372753PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Shikimate dehydrogenase (aroE) CSB-YP372754PYF
CSB-EP372754PYF
CSB-BP372754PYF
CSB-MP372754PYF
CSB-EP372754PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP372755PYF
CSB-EP372755PYF
CSB-BP372755PYF
CSB-MP372755PYF
CSB-EP372755PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Aspartate carbamoyltransferase (pyrB) CSB-YP372756PYF
CSB-EP372756PYF
CSB-BP372756PYF
CSB-MP372756PYF
CSB-EP372756PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pelobacter propionicus Dihydroxy-acid dehydratase (ilvD), partial CSB-YP372757PYF
CSB-EP372757PYF
CSB-BP372757PYF
CSB-MP372757PYF
CSB-EP372757PYF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>